Search

Your search keyword '"Gary D. Clark"' showing total 89 results

Search Constraints

Start Over You searched for: Author "Gary D. Clark" Remove constraint Author: "Gary D. Clark"
89 results on '"Gary D. Clark"'

Search Results

1. Long‐term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3‐year results from the cannabidiol expanded access program

2. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

3. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

4. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

5. Neurology in a Pandemic

6. The Finances of Neurology in a Major Children's Hospital

7. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

8. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

9. One is the loneliest number: genotypic matchmaking using the electronic health record

10. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

12. Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder

13. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

14. Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency

15. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma

16. Novel Treatments and Clinical Research in Child Neurology

17. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

18. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

19. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

20. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

21. Clinical Profile and Long-Term Outcome in Neonatal Cerebral Sinus Venous Thrombosis

22. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

23. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor beta Signaling

24. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

25. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

26. The Pafah1b complex interacts with the reelin receptor VLDLR.

28. The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease

29. A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay

30. A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3

31. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

32. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

33. Case report of prenatal bilateral cerebellar infarction: implications for social-behavioral functioning

34. IRF2BPL Is Associated with Neurological Phenotypes

35. A Comprehensive Iterative Approach is Highly Effective in Diagnosing Individuals who are Exome Negative

36. Cockayne Syndrome Complicated by Moyamoya Vasculopathy and Stroke

37. Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes

38. Infant Botulism With Asymmetric Cranial Nerve Palsies

39. Evaluation of Safety in Exceeding Maximum Adult Doses of Commonly Used Second-Generation Antiepileptic Drugs in Pediatric Patients

40. Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases

41. MARRVEL: Integration of Human and Model Organism Genetic Resources to Facilitate Functional Annotation of the Human Genome

42. Recurrent Muscle Weakness with Rhabdomyolysis, Metabolic Crises, and Cardiac Arrhythmia Due to Bi-allelic TANGO2 Mutations

43. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype

44. Whole-exome sequencing identifies compound heterozygous mutations in WDR62 in siblings with recurrent polymicrogyria

45. Recurrent partial rhombencephalosynapsis and holoprosencephaly in siblings with a mutation of ZIC2

46. Bilateral In Utero Cerebellar Infarction

47. Angioplasty for Acute Stroke With Pediatric Moyamoya Syndrome

48. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size

49. Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region

50. Platelet-Activating Factor Acetylhydrolase and Brain Development

Catalog

Books, media, physical & digital resources